相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Therapeutic potential of ReACp53 targeting mutant p53 protein in CRPC
Yaqun Zhang et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2020)
Association between endometriosis and gynecological cancers: a critical review of the literature
Dimitrios Rafail Kalaitzopoulos et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2020)
JQ1 inhibits tumour growth in combination with cisplatin and suppresses JAK/STAT signalling pathway in ovarian cancer
Tina Bagratuni et al.
EUROPEAN JOURNAL OF CANCER (2020)
Low-grade serous ovarian cancer: State of the science
Brian Slomovitz et al.
GYNECOLOGIC ONCOLOGY (2020)
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes
Laura Fachal et al.
NATURE GENETICS (2020)
Non-coding somatic mutations converge on the PAX8 pathway in ovarian cancer
Rosario Corona et al.
NATURE COMMUNICATIONS (2020)
Prostate cancer reactivates developmental epigenomic programs during metastatic progression
Mark M. Pomerantz et al.
NATURE GENETICS (2020)
Ovarian Carcinoma Histotype: Strengths and Limitations of Integrating Morphology With Immunohistochemical Predictions
Martin Kobel et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2019)
Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage
Lauren C. Peres et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage
Lauren C. Peres et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
Targeting PI3K in cancer: mechanisms and advances in clinical trials
Jing Yang et al.
MOLECULAR CANCER (2019)
Mucinous Ovarian Carcinoma
Philippe Morice et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Clinicopathological correlation of ARID1A status with HDAC6 and its related factors in ovarian clear cell carcinoma
Mitsutake Yano et al.
SCIENTIFIC REPORTS (2019)
MYC status as a determinant of synergistic response to Olaparib and Palbociclib in ovarian cancer
Jingyan Yi et al.
EBIOMEDICINE (2019)
Tubal Origin of Ovarian Low-Grade Serous Carcinoma: A Gene Expression Profile Study
Yiying Wang et al.
JOURNAL OF ONCOLOGY (2019)
PARAGON: A Phase II study of anastrozole in patients with estrogen receptor-positive recurrent/metastatic low-grade ovarian cancers and serous borderline ovarian tumors
Monica Tang et al.
GYNECOLOGIC ONCOLOGY (2019)
Proteomic analysis reveals a role for PAX8 in peritoneal colonization of high grade serous ovarian cancer that can be targeted with micelle encapsulated thiostrepton
Laura R. Hardy et al.
ONCOGENE (2019)
Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: old actors and new players
Xiaotian Yuan et al.
ONCOGENE (2019)
Prognostic significance of the EVI1 gene expression in patients with acute myeloid leukemia: a meta-analysis
Xia Wu et al.
ANNALS OF HEMATOLOGY (2019)
Correlation of NRF2 and progesterone receptor and its effects on ovarian cancer biology
Bastian Czogalla et al.
CANCER MANAGEMENT AND RESEARCH (2019)
PARP Inhibitor Resistance: A Tug-of-War in BRCA-Mutated Cells
Sylvie M. Noordermeer et al.
TRENDS IN CELL BIOLOGY (2019)
The molecular origin and taxonomy of mucinous ovarian carcinoma
Dane Cheasley et al.
NATURE COMMUNICATIONS (2019)
Both fallopian tube and ovarian surface epithelium are cells-of-origin for high-grade serous ovarian carcinoma
Shuang Zhang et al.
NATURE COMMUNICATIONS (2019)
Phase I/II clinical trial of a Wilms' tumor 1-targeted dendritic cell vaccination-based immunotherapy in patients with advanced cancer
Wen Zhang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Interaction of ER and NRF2 Impacts Survival in Ovarian Cancer Patients
Bastian Czogalla et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Therapeutic Inhibition of Myc in Cancer. Structural Bases and Computer-Aided Drug Discovery Approaches
Lavinia A. Carabet et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
COSMIC: the Catalogue Of Somatic Mutations In Cancer
John G. Tate et al.
NUCLEIC ACIDS RESEARCH (2019)
Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors
Charles Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
A Study of High-Grade Serous Ovarian Cancer Origins Implicates the SOX18 Transcription Factor in Tumor Development
Kate Lawrenson et al.
CELL REPORTS (2019)
Regulation of REG4 Expression and Prediction of 5-Fluorouracil Sensitivity by CDX2 in Ovarian Mucinous Carcinoma
Iemasa Koh et al.
CANCER GENOMICS & PROTEOMICS (2019)
Accurate prediction of cell type-specific transcription factor binding
Jens Keilwagen et al.
GENOME BIOLOGY (2019)
BRCA mutation in high grade epithelial ovarian cancers
Tarinee Manchana et al.
GYNECOLOGIC ONCOLOGY REPORTS (2019)
PARAGON (ANZGOG-0903): a phase 2 study of anastrozole in asymptomatic patients with estrogen and progesterone receptor-positive recurrent ovarian cancer and CA125 progression
Peey-Sei Kok et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2019)
Long Non-Coding RNA LINC00511 Mediates the Effects of ESR1 on Proliferation and Invasion of Ovarian Cancer Through miR-424-5p and miR-370-5p
Kang Wang et al.
CANCER MANAGEMENT AND RESEARCH (2019)
BRCA1 gene: function and deficiency
Miho Takaoka et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2018)
Targeting acute myeloid leukemia by drug-induced c-MYB degradation
V. Walf-Vorderwulbecke et al.
LEUKEMIA (2018)
Novel cooperative pathway of c-Myc and Furin, a pro-protein convertase, in cell proliferation as a therapeutic target in ovarian cancers
Junko Hasegawa-Minato et al.
ONCOTARGET (2018)
Is Myc an Important Biomarker? Myc Expression in Immune Disorders and Cancer
Shivtia Trop-Steinberg et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2018)
Cysteine boosters the evolutionary adaptation to CoCl2 mimicked hypoxia conditions, favouring carboplatin resistance in ovarian cancer
Sofia C. Nunes et al.
BMC EVOLUTIONARY BIOLOGY (2018)
The Human Transcription Factors
Samuel A. Lambert et al.
CELL (2018)
Recent Insights into Mucinous Ovarian Carcinoma
Francesca Ricci et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
New therapeutic strategies to treat human cancers expressing mutant p53 proteins
Giovanni Blandino et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Olaparib-induced Adaptive Response Is Disrupted by FOXM1 Targeting that Enhances Sensitivity to PARP Inhibition
Pingping Fang et al.
MOLECULAR CANCER RESEARCH (2018)
Targeting Transcription Factors for Cancer Treatment
Melanie Lambert et al.
MOLECULES (2018)
PAX8 activates a p53-p21-dependent pro-proliferative effect in high grade serous ovarian carcinoma
Dima Ghannam-Shahbari et al.
ONCOGENE (2018)
GREB1 is an estrogen receptor-regulated tumour promoter that is frequently expressed in ovarian cancer
Kendra Hodgkinson et al.
ONCOGENE (2018)
Targeting estrogen receptor beta (ERβ) for treatment of ovarian cancer: importance of KDM6B and SIRT1 for ERβ expression and functionality
Giulia Pinton et al.
ONCOGENESIS (2018)
Regulation of the master regulator FOXM1 in cancer
Guo-Bin Liao et al.
CELL COMMUNICATION AND SIGNALING (2018)
Primordial germ cells as a potential shared cell of origin for mucinous cystic neoplasms of the pancreas and mucinous ovarian tumors
Kevin M. Elias et al.
JOURNAL OF PATHOLOGY (2018)
BRD4 amplification facilitates an oncogenic gene expression program in high-grade serous ovarian cancer and confers sensitivity to BET inhibitors
Garrett W. Rhyasen et al.
PLOS ONE (2018)
Association between contemporary hormonal contraception and ovarian cancer in women of reproductive age in Denmark: prospective, nationwide cohort study
Lisa Iversen et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
UnPAXing the Divergent Roles of PAX2 and PAX8 in High-Grade Serous Ovarian Cancer
Laura R. Hardy et al.
CANCERS (2018)
Estrogen receptor β is associated with expression of cancer associated genes and survival in ovarian cancer
Susanne Schueler-Toprak et al.
BMC CANCER (2018)
TRPS1 Is a Lineage-Specific Transcriptional Dependency in Breast Cancer
Robert M. Witwicki et al.
CELL REPORTS (2018)
Integrated Genomic, Epigenomic, and Expression Analyses of Ovarian Cancer Cell Lines
Eniko Papp et al.
CELL REPORTS (2018)
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13
Mei Zeng et al.
ELIFE (2018)
Napsin A and WT 1 are useful immunohistochemical markers for differentiating clear cell carcinoma ovary from high-grade serous carcinoma
Bharat Rekhi et al.
APMIS (2018)
NANOG regulates epithelial-mesenchymal transition and chemoresistance in ovarian cancer
Shan Qin et al.
BIOSCIENCE REPORTS (2017)
Endocrine therapy in epithelial ovarian cancer
Simon P. Langdon et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2017)
DLX1 acts as a crucial target of FOXM1 to promote ovarian cancer aggressiveness by enhancing TGF-β/SMAD4 signaling
D. W. Chan et al.
ONCOGENE (2017)
Phase 2 trial of everolimus and letrozole in relapsed estrogen receptor-positive high-grade ovarian cancers
Gerardo Colon-Otero et al.
GYNECOLOGIC ONCOLOGY (2017)
Hormonal Maintenance Therapy for Women With Low-Grade Serous Cancer of the Ovary or Peritoneum
David M. Gershenson et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients
Renata A. Tassi et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells
Robin M. Meyers et al.
NATURE GENETICS (2017)
Synthetic lethality and cancer
Nigel J. O'Neil et al.
NATURE REVIEWS GENETICS (2017)
High grade serous ovarian carcinomas originate in the fallopian tube
S. Intidhar Labidi-Galy et al.
NATURE COMMUNICATIONS (2017)
The PAX8 cistrome in epithelial ovarian cancer
Emily K. Adler et al.
ONCOTARGET (2017)
Hepatocyte Nuclear Factor-1β Expression in Clear Cell Renal Cell Carcinoma and Urothelial Carcinoma With Clear Cell Features: A Potential Diagnostic Pitfall
Krisztina Z. Hanley et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2017)
Wilms' tumour 1 (WT1) in development, homeostasis and disease
Nicholas D. Hastie
DEVELOPMENT (2017)
Effect of estrogen receptor β agonists on proliferation and gene expression of ovarian cancer cells
Susanne Schueler-Toprak et al.
BMC CANCER (2017)
A prospective cohort study of oral contraceptive use and ovarian cancer among women in the United States born from 1947 to 1964
Amy L. Shafrir et al.
CANCER CAUSES & CONTROL (2017)
Loss of BRCA1 in the Cells of Origin of Ovarian Cancer Induces Glycolysis: A Window of Opportunity for Ovarian Cancer Chemoprevention
Tatsuyuki Chiyoda et al.
CANCER PREVENTION RESEARCH (2017)
Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci
Siddhartha P. Kar et al.
BRITISH JOURNAL OF CANCER (2017)
Chemotherapy vs tamoxifen in platinum-resistant ovarian cancer: a phase III, randomised, multicentre trial (Ovaresist)
Kristina Lindemann et al.
BRITISH JOURNAL OF CANCER (2017)
Transcriptional Addiction in Cancer
James E. Bradner et al.
CELL (2017)
The role of NANOG transcriptional factor in the development of malignant phenotype of cancer cells
Natalia Gawlik-Rzemieniewska et al.
CANCER BIOLOGY & THERAPY (2016)
Functional features of EVI1 and EVI1Δ324 isoforms of MECOM gene in genome-wide transcription regulation and oncogenicity
A. Sayadi et al.
ONCOGENE (2016)
Phase II study of Vigil DNA engineered immunotherapy as maintenance in advanced stage ovarian cancer
Jonathan Oh et al.
GYNECOLOGIC ONCOLOGY (2016)
Wilms tumor protein 1 (WT1) - Not only a diagnostic but also a prognostic marker in high-grade serous ovarian carcinoma
Eliane Tabea Taube et al.
GYNECOLOGIC ONCOLOGY (2016)
The prognostic significance of specific HOX gene expression patterns in ovarian cancer
Zoe Kelly et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
The Application Value of HNF-1β Transcription Factor in the Diagnosis of Ovarian Clear Cell Carcinoma
Qing Li et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2016)
HiChIP: efficient and sensitive analysis of protein-directed genome architecture
Maxwell R. Mumbach et al.
NATURE METHODS (2016)
An interaction proteomics survey of transcription factor binding at recurrent TERT promoter mutations
Matthew M. Makowski et al.
PROTEOMICS (2016)
NANOG regulates epithelial-mesenchymal transition and chemoresistance through activation of the STAT3 pathway in epithelial ovarian cancer
Suqing Liu et al.
TUMOR BIOLOGY (2016)
Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation
Alexander Gusev et al.
NATURE COMMUNICATIONS (2016)
Loss of PAX8 in high-grade serous ovarian cancer reduces cell survival despite unique modes of action in the fallopian tube and ovarian surface epithelium
Laura H. Rodgers et al.
ONCOTARGET (2016)
Regulation of multidrug resistance 1 expression by CDX2 in ovarian mucinous adenocarcinoma
Iemasa Koh et al.
CANCER MEDICINE (2016)
Divergent Roles of PAX2 in the Etiology and Progression of Ovarian Cancer
Ensaf M. Al-Hujaily et al.
CANCER PREVENTION RESEARCH (2015)
3q26/EVI1 rearrangements in myeloid hemopathies: a cytogenetic review
Marc De Braekeleer et al.
FUTURE ONCOLOGY (2015)
TP53 hot spot mutations in ovarian cancer: Selective resistance to microtubule stabilizers in vitro and differential survival outcomes from The Cancer Genome Atlas
Brandon-Luke L. Seagle et al.
GYNECOLOGIC ONCOLOGY (2015)
Beyond genomics: Critical evaluation of cell line utility for ovarian cancer research
Kevin M. Elias et al.
GYNECOLOGIC ONCOLOGY (2015)
In vivo tumor growth of high-grade serous ovarian cancer cell lines
Anirban K. Mitra et al.
GYNECOLOGIC ONCOLOGY (2015)
Integration of multiethnic fine-mapping and genomic annotation to prioritize candidate functional SNPs at prostate cancer susceptibility regions
Ying Han et al.
HUMAN MOLECULAR GENETICS (2015)
Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT) A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology
Donavan T. Cheng et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2015)
Transcriptional upregulation of HNF-1 beta by NF-kappa B in ovarian clear cell carcinoma modulates susceptibility to apoptosis through alteration in bcl-2 expression
Erina Suzuki et al.
LABORATORY INVESTIGATION (2015)
Targeting c-MYC in Platinum-Resistant Ovarian Cancer
Jeyshka M. Reyes-Gonzalez et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Non-coding recurrent mutations in chronic lymphocytic leukaemia
Xose S. Puente et al.
NATURE (2015)
Progesterone receptor modulates ERα action in breast cancer
Hisham Mohammed et al.
NATURE (2015)
Genome-wide significant risk associations for mucinous ovarian carcinoma
Linda E. Kelemen et al.
NATURE GENETICS (2015)
CAUSEL: an epigenome- and genome-editing pipeline for establishing function of noncoding GWAS variants
Sandor Spisak et al.
NATURE MEDICINE (2015)
Unraveling the 3D genome: genomics tools for multiscale exploration
Viviano I. Risca et al.
TRENDS IN GENETICS (2015)
Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer
Kate Lawrenson et al.
NATURE COMMUNICATIONS (2015)
FOXM1 is a downstream target of LPA and YAP oncogenic signaling pathways in high grade serous ovarian cancer
Qipeng Fan et al.
ONCOTARGET (2015)
Metabolic alterations caused by HNF1β expression in ovarian clear cell carcinoma contribute to cell survival
Yasuaki Amano et al.
ONCOTARGET (2015)
Hepatocyte Nuclear Factor-1 beta (HNF-1 beta) Promotes Glucose Uptake and Glycolytic Activity in Ovarian Clear Cell Carcinoma
Takako Okamoto et al.
MOLECULAR CARCINOGENESIS (2015)
An in-tumor genetic screen reveals that the BET bromodomain protein, BRD4, is a potential therapeutic target in ovarian carcinoma
Maria Giuseppina Baratta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Targeting Transcription Factors in Cancer
Anand S. Bhagwat et al.
TRENDS IN CANCER (2015)
A role for PAX8 in the tumorigenic phenotype of ovarian cancer cells
Tina Di Palma et al.
BMC CANCER (2014)
POSTN/TGFBI-associated stromal signature predicts poor prognosis in serous epithelial ovarian cancer
Beth Y. Karlan et al.
GYNECOLOGIC ONCOLOGY (2014)
HOX genes and their role in the development of human cancers
Seema Bhatlekar et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2014)
An overview of current and emerging SERMs
Barry S. Komm et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2014)
Estrogen signaling crosstalk: Implications for endocrine resistance in ovarian cancer
Jennifer R. Ribeiro et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2014)
Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles
Melissa K. McConechy et al.
MODERN PATHOLOGY (2014)
By inhibiting Sic, verapamil and dasatinib overcome multidrug resistance via increased expression of Bim and decreased expressions of MDR1 and survivin in human multidrug-resistant myeloma cells
Masanobu Tsubaki et al.
LEUKEMIA RESEARCH (2014)
Targeting transcription regulation in cancer with a covalent CDK7 inhibitor
Nicholas Kwiatkowski et al.
NATURE (2014)
Obesity-associated variants within FTO form long-range functional connections with IRX3
Scott Smemo et al.
NATURE (2014)
Selective transcriptional regulation by Myc in cellular growth control and lymphomagenesis
Arianna Sabo et al.
NATURE (2014)
The PI3K/mTOR dual inhibitor NVP-BEZ235 reduces the growth of ovarian clear cell carcinoma
Tetsuro Oishi et al.
ONCOLOGY REPORTS (2014)
Overexpression of Forkhead Box Protein M1 (FOXM1) in Ovarian Cancer Correlates with Poor Patient Survival and Contributes to Paclitaxel Resistance
Fung Zhao et al.
PLOS ONE (2014)
An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element
Marc R. Mansour et al.
SCIENCE (2014)
Hypoxia-Inducible Factor 3 Is an Oxygen-Dependent Transcription Activator and Regulates a Distinct Transcriptional Response to Hypoxia
Peng Zhang et al.
CELL REPORTS (2014)
Comprehensive Functional Annotation of 77 Prostate Cancer Risk Loci
Dennis J. Hazelett et al.
PLOS GENETICS (2014)
Expression of REG4 in Ovarian Mucinous Tumors
Qiong Huang et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2014)
Transformation of the Fallopian Tube Secretory Epithelium Leads to High-Grade Serous Ovarian Cancer in Brca;Tp53;Pten Models
Ruth Perets et al.
CANCER CELL (2013)
PTEN loss and HOXA10 expression are associated with ovarian endometrioid adenocarcinoma differentiation and progression
Pradeep S. Tanwar et al.
CARCINOGENESIS (2013)
Integrative eQTL-Based Analyses Reveal the Biology of Breast Cancer Risk Loci
Qiyuan Li et al.
CELL (2013)
ARID1A Mutations and PI3K/AKT Pathway Alterations in Endometriosis and Endometriosis-Associated Ovarian Carcinomas
Eleftherios P. Samartzis et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
The Consequence of Oncomorphic TP53 Mutations in Ovarian Cancer
Pavla Brachova et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study
Weiva Sieh et al.
LANCET ONCOLOGY (2013)
Mutational landscape and significance across 12 major cancer types
Cyriac Kandoth et al.
NATURE (2013)
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer
Paul D. P. Pharoah et al.
NATURE GENETICS (2013)
Oral Contraceptive Pills as Primary Prevention for Ovarian Cancer A Systematic Review and Meta-analysis
Laura J. Havrilesky et al.
OBSTETRICS AND GYNECOLOGY (2013)
Stem cell transcription factor NANOG controls cell migration and invasion via dysregulation of E-cadherin and FoxJ1 and contributes to adverse clinical outcome in ovarian cancers
M. K. Y. Siu et al.
ONCOGENE (2013)
Integrative Bioinformatics Links HNF1B with Clear Cell Carcinoma and Tumor-Associated Thrombosis
Justin Cuff et al.
PLOS ONE (2013)
Master regulators of FGFR2 signalling and breast cancer risk
Michael N. C. Fletcher et al.
NATURE COMMUNICATIONS (2013)
Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer
Hui Shen et al.
NATURE COMMUNICATIONS (2013)
Evaluating cell lines as tumour models by comparison of genomic profiles
Silvia Domcke et al.
NATURE COMMUNICATIONS (2013)
Core Transcriptional Regulatory Circuit Controlled by the TAL1 Complex in Human T Cell Acute Lymphoblastic Leukemia
Takaomi Sanda et al.
CANCER CELL (2012)
Transcriptional Amplification in Tumor Cells with Elevated c-Myc
Charles Y. Lin et al.
CELL (2012)
Prognostic Impact of the Cancer Stem Cell-Related Marker NANOG in Ovarian Serous Carcinoma
Maria Lee et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2012)
Progesterone receptors, their isoforms and progesterone regulated transcription
Britta M. Jacobsen et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2012)
Phase I Trial of bi-shRNAifurin/GMCSF DNA/Autologous Tumor Cell Vaccine (FANG) in Advanced Cancer
Neil Senzer et al.
MOLECULAR THERAPY (2012)
Breast cancer risk-associated SNPs modulate the affinity of chromatin for FOXA1 and alter gene expression
Richard Cowper-Sal-lari et al.
NATURE GENETICS (2012)
Transcription factors: from enhancer binding to developmental control
Francois Spitz et al.
NATURE REVIEWS GENETICS (2012)
Targeting GRB7/ERK/FOXM1 Signaling Pathway Impairs Aggressiveness of Ovarian Cancer Cells
David W. Chan et al.
PLOS ONE (2012)
Ecotopic viral integration site 1 (EVI1) regulates multiple cellular processes important for cancer and is a synergistic partner for FOS protein in invasive tumors
Emilie A. Bard-Chapeau et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Deconstructing p53 transcriptional networks in tumor suppression
Kathryn T. Bieging et al.
TRENDS IN CELL BIOLOGY (2012)
A Comprehensive Analysis of PAX8 Expression in Human Epithelial Tumors
Anna R. Laury et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
Global analysis of estrogen receptor beta binding to breast cancer cell genome reveals an extensive interplay with estrogen receptor alpha for target gene regulation
Oli M. V. Grober et al.
BMC GENOMICS (2011)
A Pin1/Mutant p53 Axis Promotes Aggressiveness in Breast Cancer
Javier E. Girardini et al.
CANCER CELL (2011)
Modelling genetic and clinical heterogeneity in epithelial ovarian cancers
Kate Lawrenson et al.
CARCINOGENESIS (2011)
Oral contraceptives and risk of ovarian and breast cancers in BRCA mutation carriers: a meta-analysis
David Cibula et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2011)
Frequency of mismatch repair deficiency in ovarian cancer: a systematic review
Megan A. Murphy et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
FOXA1 is a key determinant of estrogen receptor function and endocrine response
Antoni Hurtado et al.
NATURE GENETICS (2011)
PAX8 promotes tumor cell growth by transcriptionally regulating E2F1 and stabilizing RB protein
C. G. Li et al.
ONCOGENE (2011)
MSX2 is an oncogenic downstream target of activated WNT signaling in ovarian endometrioid adenocarcinoma
Y. Zhai et al.
ONCOGENE (2011)
Mammalian Target of Rapamycin Is a Therapeutic Target for Murine Ovarian Endometrioid Adenocarcinomas with Dysregulated Wnt/β-Catenin and PTEN
Pradeep S. Tanwar et al.
PLOS ONE (2011)
Aberrant Activation of ERK/FOXM1 Signaling Cascade Triggers the Cell Migration/Invasion in Ovarian Cancer Cells
Gabriel T. M. Lok et al.
PLOS ONE (2011)
Modeling high-grade serous ovarian carcinogenesis from the fallopian tube
Alison M. Karst et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer
Hiu Wing Cheung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
Robert J. Kurman et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)
Mutant p53 R248Q but not R248W enhances in vitro invasiveness of human lung cancer NCI-H1299 cells
Kazuhito Yoshikawa et al.
BIOMEDICAL RESEARCH-TOKYO (2010)
CDX2 Regulates Multidrug Resistance 1 Gene Expression in Malignant Intestinal Epithelium
Yuji Takakura et al.
CANCER RESEARCH (2010)
DNA Copy Numbers Profiles in Affinity-Purified Ovarian Clear Cell Carcinoma
Kuan-Ting Kuo et al.
CLINICAL CANCER RESEARCH (2010)
Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary
Ashour Ahmed Ahmed et al.
JOURNAL OF PATHOLOGY (2010)
A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24
Llen L. Goode et al.
NATURE GENETICS (2010)
Researchers find a new cancer gene and a possible link between ovarian cancer and endometriosis
[Anonymous]
WOMENS HEALTH (2010)
Identification of an ovarian clear cell carcinoma gene signature that reflects inherent disease biology and the carcinogenic processes
K. Yamaguchi et al.
ONCOGENE (2010)
8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC
Nasim Ahmadiyeh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
Sian Jones et al.
SCIENCE (2010)
Transcriptional Regulation by p53
Rachel Beckerman et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
ARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas
Kimberly C. Wiegand et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
A Mutant-p53/Smad Complex Opposes p63 to Empower TGFβ-Induced Metastasis
Maddalena Adorno et al.
CELL (2009)
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
Martin A. Cheever et al.
CLINICAL CANCER RESEARCH (2009)
Hormone Therapy and Ovarian Cancer
Lina Steinrud Morch et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
WT1 represses HOX gene expression in the regulation of gynaecologic tumour histologic type
Vaagn Andikyan et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
PAX2 expression in low malignant potential ovarian tumors and low-grade ovarian serous carcinomas
Celestine S. Tung et al.
MODERN PATHOLOGY (2009)
The Contribution of BRCA1 and BRCA2 to Ovarian Cancer
Susan J. Ramus et al.
MOLECULAR ONCOLOGY (2009)
An oestrogen-receptor-α-bound human chromatin interactome
Melissa J. Fullwood et al.
NATURE (2009)
Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1
Wei Zheng et al.
NATURE GENETICS (2009)
RNA-Seq: a revolutionary tool for transcriptomics
Zhong Wang et al.
NATURE REVIEWS GENETICS (2009)
Acute promyelocytic leukemia: from highly fatal to highly curable
Zhen-Yi Wang et al.
BLOOD (2008)
Identification and characterization of ovarian cancer-initiating cells from primary human tumors
Shu Zhang et al.
CANCER RESEARCH (2008)
Conditional RNA interference in vivo to study mutant p53 oncogenic gain of function on tumor malignancy
Gianluca Bossi et al.
CELL CYCLE (2008)
Targeting the androgen receptor pathway in prostate cancer
Yu Chen et al.
CURRENT OPINION IN PHARMACOLOGY (2008)
Efficacy of letrozole in the treatment of recurrent platinum- and taxane-resistant high-grade cancer of the ovary or peritoneum
Pedro T. Ramirez et al.
GYNECOLOGIC ONCOLOGY (2008)
Wnt signaling in ovarian tumorigenesis
T. A. Gatcliffe et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2008)
Multiple loci with different cancer specificities within the 8q24 gene desert
Maya Ghoussaini et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23 257 women with ovarian cancer and 87 303 controls
V. Beral et al.
LANCET (2008)
Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies
Martin Koebel et al.
PLOS MEDICINE (2008)
Hypomethylation of hepatocyte nuclear factor-1beta (HNF-1beta) CpG island in clear cell carcinoma of the ovary
Noriko Kato et al.
VIRCHOWS ARCHIV (2008)
Over-expression of hypoxia-inducible factor 1 alpha in ovarian clear cell carcinoma
Sunyoung Lee et al.
GYNECOLOGIC ONCOLOGY (2007)
Expression level of Wilms tumor 1 (WT1) protein has limited prognostic value in epithelial ovarian cancer - From the Danish MALOVA Ovarian Cancer Study
Estrid V. S. Hogdall et al.
GYNECOLOGIC ONCOLOGY (2007)
Genome-wide association study identifies novel breast cancer susceptibility loci
Douglas F. Easton et al.
NATURE (2007)
Ovarian cancer and hormone replacement therapy in the Million Women Study
Valerie Beral et al.
LANCET (2007)
P53 gain-of-function cancer mutants induce genetic instability by inactivating ATM
Hoseok Song et al.
NATURE CELL BIOLOGY (2007)
Amplification of MDS1/EVI1 and EVI1, located in the 3q26.2 amplicon, is associated with favorable patient prognosis in ovarian cancer
Meera Nanjundan et al.
CANCER RESEARCH (2007)
Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: A kin-cohort study in Ontario, Canada
Harvey A. Risch et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Immunohistochemical expression of CDX2 in primary ovarian mucinous tumors and metastatic mucinous carcinomas involving the ovary: comparison with CK20 and correlation with coordinate expression of CK7
Russell Vang et al.
MODERN PATHOLOGY (2006)
The role of BRCA1 in transcriptional regulation and cell cycle control
P. B. Mullan et al.
ONCOGENE (2006)
Gain of function of mutant p53: The mutant p53/NF-Y protein complex reveals an aberrant transcriptional mechanism of cell cycle regulation
Silvia Di Agostino et al.
CANCER CELL (2006)
Lineage dependency and lineage-survival oncogenes in human cancer
Levi A. Garraway et al.
NATURE REVIEWS CANCER (2006)
WTI gene expression as a prognostic marker in advanced serous epithelial ovarian carcinoma: an immunohistochemical study
Wirote Netinatsunthorn et al.
BMC CANCER (2006)
A distinct molecular profile associated with mucinous epithelial ovarian cancer
VA Heinzelmann-Schwarz et al.
BRITISH JOURNAL OF CANCER (2006)
Expression of hepatocyte nuclear factor-1beta (HNF-1beta) in clear cell tumors and endometriosis of the ovary
N Kato et al.
MODERN PATHOLOGY (2006)
BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases
T Pal et al.
CANCER (2005)
Core transcriptional regulatory circuitry in human embryonic stem cells
LA Boyer et al.
CELL (2005)
Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1
JS Carroll et al.
CELL (2005)
Lineage infidelity of epithelial ovarian cancers is controlled by HOX genes that specify regional identity in the reproductive tract
WJ Cheng et al.
NATURE MEDICINE (2005)
Regulation of the estrogen-inducible gene expression profile by the breast cancer susceptibility gene BRCA1
JW Xu et al.
ENDOCRINOLOGY (2005)
FGF-20 and DKK1 are transcriptional targets of β-catenin and FGF-20 is implicated in cancer and development
MN Chamorro et al.
EMBO JOURNAL (2005)
Hepatocyte paraffin 1 antibody does not distinguish primary ovarian tumors with hepatoid differentiation from metastatic hepatocellular carcinoma
MB Pitman et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2004)
Tumor-derived p53 mutants induce oncogenesis by transactivating growth-promoting genes
MJ Scian et al.
ONCOGENE (2004)
The value of Cdx2 immunostaining in differentiating primary ovarian carcinomas from colonic carcinomas metastatic to the ovaries
GM Groisman et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2004)
Phase II trial of anastrozole in women with asymptomatic mullerian cancer
MG del Carmen et al.
GYNECOLOGIC ONCOLOGY (2003)
Endothelial and steroidogenic cell migration are regulated by WNT4 in the developing mammalian gonad
K Jeays-Ward et al.
DEVELOPMENT (2003)
Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells
I Chambers et al.
CELL (2003)
The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells
K Mitsui et al.
CELL (2003)
Expression profiling in ovarian clear cell carcinoma identification of hepatocyte nuclear factor-1 beta as a molecular marker and a possible molecular target for therapy of ovarian clear cell carcinoma
A Tsuchiya et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Expression of CDX2 in normal and neoplastic human colon tissue and during differentiation of an in vitro model system
D Qualtrough et al.
GUT (2002)
Role of β-catenin/T-cell factor-regulated genes in ovarian endometrioid adenocarcinomas
Y Zhai et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
HIF-1 and tumor progression: pathophysiology and therapeutics
GL Semenza
TRENDS IN MOLECULAR MEDICINE (2002)
BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor
L Zheng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Menopause and hormone-replacement therapy: Part 2. Hormone-replacement therapy regimens
S Ratner et al.
WESTERN JOURNAL OF MEDICINE (2001)
Increase of androgen-induced cell death and androgen receptor transactivation by BRCA1 in prostate cancer cells
SY Yeh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Immunohistochemical detection of the Wilms' tumor gene (WT1) in epithelial ovarian tumors
M Shimizu et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2000)
分享论文
